Magnesium+B6 Pharmavit

Quick links

Choose a section

Quick links to important sections

Advertisements

Magnesium+B6 Pharmavit

Advertisements
Advertisements

Overview of Magnesium+B6 Pharmavit

Quick Facts

Property Description
Active ingredient Magnesium salt and Pyridoxine Hydrochloride (Vitamin B6)
Form Solid oral form (e.g., film-coated tablets)
Pharmacological class Mineral and Vitamin Complex; Metabolic agent
Common purpose Replenishment of essential micronutrients
Origin Synthetically produced salts

What Type of Preparation is Magnesium+B6 Pharmavit?

Magnesium+B6 Pharmavit is classified as a fixed-dose combination product belonging to the mineral and vitamin complex pharmacological group. Its primary function is to serve as an essential micronutrient supplement, typically administered via the oral route in the form of a film-coated tablet. The preparation is formulated as a metabolic agent to address potential shortfalls of the two active ingredients simultaneously, differentiating it from single-component supplements.


Composition: The Combined Role of Magnesium and Pyridoxine

The active composition includes the essential mineral Magnesium and Pyridoxine Hydrochloride, which is the salt form of Vitamin B6. The components are synthetically produced as pharmacologically active salts and delivered within an inert excipient matrix. The formulation utilizes the principle of metabolic synergy: Pyridoxine supports the cellular uptake and retention of the magnesium ion. Magnesium is a required cofactor for over 300 enzymatic reactions in the human body, fundamental to cellular energy and function.


General Purpose and Differentiation

The general purpose of the preparation is to restore and maintain the physiological balance of these two crucial cofactors. By ensuring an adequate supply, the product helps to support normal nervous system and muscle function and contributes to the alleviation of symptoms associated with their deficiency. Pyridoxine is vital for normal brain and nervous system health. The Magnesium+B6 combination is used for supporting individuals experiencing symptoms like muscle twitching or heightened fatigue. As a brand, Magnesium+B6 Pharmavit is typically marketed as an over-the-counter (OTC) supplement, focusing on adults seeking relief from stress-related exhaustion or mild muscular discomfort.

Regulatory References

  1. NIH Fact Sheet on Magnesium
Advertisements

What side effects are possible with Magnesium+B6 Pharmavit?

Possible Side Effects and Safety Information

The safety profile for this combination product primarily involves the risk profiles of its two active components, Magnesium and Vitamin B6 (Pyridoxine).


Adverse Reactions and General Safety

Adverse reactions associated with magnesium typically affect the gastrointestinal system. These may include, but are not limited to, stomach upset, nausea, vomiting, flatulence, and diarrhea. Such effects are generally considered dose-related and may be alleviated by reducing the amount taken.

Serious and Clinically Significant Risks

Peripheral Neuropathy (Vitamin B6)

The most significant safety concern linked to the Vitamin B6 component is the potential for peripheral neuropathy, a form of nerve damage characterized by symptoms such as tingling, burning, or numbness in the hands and feet. This condition is dose- and duration-dependent, primarily occurring with high doses or prolonged exposure. Regulatory bodies have noted that neuropathy may occur even at daily B6 doses below 50 mg, especially when individuals take multiple supplements containing Vitamin B6.

Magnesium Toxicity

At very high intakes, exceeding the established Tolerable Upper Intake Level (UL) of 350 mg per day for supplemental magnesium in adults, there is a risk of magnesium toxicity (hypermagnesemia). Severe toxicity can lead to serious cardiovascular or respiratory complications, though this is rare with typical supplementation doses.

Restrictions and Special Populations

This product is generally contraindicated (should not be used) in patients with severe renal insufficiency (poor kidney function) due to the risk of magnesium accumulation. Caution is also warranted regarding use during pregnancy and breastfeeding, as high doses of B6 can potentially be harmful. Patients with existing medical conditions or those taking multiple medications should consult a healthcare provider to assess the full risk of interaction and cumulative Vitamin B6 intake.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation on overdose addresses the distinct risks of hypermagnesemia (Magnesium toxicity) and Pyridoxine ( B6) toxicity. Overdose manifestations for Magnesium may progress from gastrointestinal upset, somnolence, and hypotension to severe neurological signs, including the loss of deep tendon reflexes (areflexia).

Severe, life-threatening outcomes such as respiratory depression, muscle paralysis, and cardiac arrest are documented risks of acute, severe magnesium overdose. Pyridoxine toxicity is primarily associated with sensory neuropathy, presenting as paraesthesia and ataxia, typically following chronic high-dose exposure.

Required Emergency Actions

Immediate medical attention or contact with a poison control center must be sought, especially if severe symptoms like difficulty breathing, muscle weakness, or confusion develop. Patients with impaired renal function face an increased risk of severe toxicity due to reduced magnesium clearance.

Management procedures officially include symptomatic and supportive treatment and the monitoring of vital signs and plasma magnesium levels. For severe hypermagnesemia, intravenous calcium gluconate is administered to counteract neuromuscular and cardiovascular effects. There is no specific antidote known for Pyridoxine toxicity.

Advertisements

Therapeutic Uses of Magnesium+B6 Pharmavit

What Magnesium+B6 Pharmavit Treats: Main Uses and Benefits

Magnesium+ B6 is used in situations involving certain distressing symptoms. Symptoms related to physical discomfort, such as muscle cramps and fatigue, may present in situations where supportive management is appropriate. This product is applied across domains where additional symptomatic support is needed to help improve day-to-day comfort.

This combination is relevant for easing symptoms associated with heightened physiological activity, including nervousness, irritability, and inner tension, as well as providing relief for involuntary muscle spasms and low energy levels. It is often used during phases when symptoms become more noticeable, providing support that helps ease the overall symptom load. This medication may assist with maintaining functional stability when symptoms interfere with routine activities.


Quick Fact: Relevant for Managing Stress and Muscle Tension

This formulation contributes to improved comfort during symptomatic periods and is applicable in scenarios where symptoms lead to temporary functional strain.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for the Magnesium+B6 combination is defined by formal contraindications and population-specific restrictions to ensure safe use.

Who Must Not Use This Medicine (Contraindications)

The medicine is absolutely contraindicated for patients diagnosed with severe renal insufficiency or renal failure, typically defined by a creatinine clearance below 30 ml/min. This restriction is mandated to prevent magnesium accumulation. Use is also prohibited for individuals with a known hypersensitivity or allergy to magnesium salts, pyridoxine (Vitamin B6), or any excipients.


Age- and Condition-Specific Eligibility

The solid oral tablet form is not recommended for children under the age of six years. Use is generally permissible for older adults unless they present with kidney function issues. The label mandates conditional use with specific caution for patients having non-severe renal impairment; this requires dosage adjustment. For pregnant or breastfeeding women, use is conditional, with an official advisory to limit the daily intake of Vitamin B6 to no more than 20 mg during lactation. Caution is also required for patients with co-existing conditions like Myasthenia Gravis.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for the combination of Magnesium salt and Pyridoxine Hydrochloride (Vitamin B6), based strictly on government regulatory documents.


Timing-Based Interaction Requirements

The most critical documented interaction involves the Magnesium component reducing the gastrointestinal absorption (exposure) of certain medicinal products due to chelation. Regulatory documents require a mandatory separation of administration timing to mitigate this effect. Substances requiring this separation include Tetracyclines, Quinolone Antibiotics, Oral Bisphosphonates, and Oral Iron Salts. Administration must typically be separated by a documented time interval, often two to three hours, from the magnesium product.

Pharmacodynamic and Exposure-Altering Interactions

Type of Interaction Interacting Substance Official Outcome
Pharmacodynamic Interference Levodopa (without decarboxylase inhibitor) High-dose Pyridoxine reduces drug effectiveness.
Reduced Absorption Digoxin Magnesium may decrease plasma concentration.
Altered Renal Handling Thiazide Diuretics May increase renal reabsorption of magnesium.

Population and Non-Drug Considerations

Interaction severity is heightened in patients with Impaired Renal Function due to a documented reduced clearance of magnesium, which increases the risk of accumulation. Furthermore, chronic alcohol consumption may increase urinary magnesium excretion, and co-administration with high doses of Calcium Salts may mutually inhibit intestinal absorption.

Advertisements

Mechanism of Action

Magnesium's Role in Modulating Neuronal Excitation

The Magnesium component fundamentally acts as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, a key mechanism for modulating excessive excitatory signaling in the central nervous system. By blocking the receptor's ion channel, Magnesium limits the flow of Ca^2+, which stabilizes the resting membrane potential of neurons and reduces hyperexcitability. This mechanism contributes to modulating processes driven by excessive neurological signaling.

Synergistic Enhancement and Calcium Antagonism

The two active components exhibit metabolic synergy to influence cellular processes. Vitamin B6 (Pyridoxine) is essential for the synthesis of the inhibitory neurotransmitter GABA, while Magnesium is a required cofactor for B6's activation into its pharmacologically active form (PLP). This collaboration contributes to the functional capacity of the inhibitory system, reinforcing the overall inhibitory tone of the CNS. At the peripheral level, Magnesium acts as a physiological Calcium antagonist, interrupting the excitation-contraction coupling cascade. This action mediates the regulation of muscle tone and decreases the likelihood of sustained muscle fiber contraction.

Advertisements

Dosage and Administration Information

How to Use Magnesium+B6 Pharmavit

The administration of Magnesium+B6 Pharmavit involves a specific method, schedule, and duration of use.

Administration Guidelines

Category Instruction Principle
Route of Administration The product is administered via the oral route, typically utilizing a solid oral form such as a film-coated tablet.
Dosing Schedule and Frequency The standard adult regimen for correcting established deficiency is 6 to 8 tablets per day, with the total daily amount divided into 2 or 3 separate intakes.
Timing and Preparation All doses are ingested with meals or immediately after food. Tablets must be swallowed whole with a substantial volume of water. The maximum daily dose must not be exceeded.
Population-Specific Use Pediatric patients (over 6 years, approximately 20 kg) are assigned a reduced regimen of 4 to 6 tablets per day. Furthermore, dosage is adjusted in individuals with severe renal function impairment.
Treatment Endpoint The treatment course is based on clinical necessity, concluding once laboratory tests confirm the correction of the underlying magnesium deficit.

Use Protocol Summary

The use of this preparation centers on oral, divided daily administration. This approach ensures that the total required daily amount is distributed across multiple intakes and timed with food. The regimen involves a specific route, a defined number of daily administrations, and a criterion for discontinuing use based on the resolution of the deficiency.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Magnesium+B6 Pharmavit

Evidence for Use in Stress, Nervousness, and Irritability

The research exploring outcomes monitoring physiological strain has centered on short-term Randomized Controlled Trials (RCTs) in adults reporting inner tension. Researchers examined patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies, but findings were mixed across different studies due to varying methods and outcome measures.

Evidence for Use in Symptoms Associated with the Menstrual Cycle

The combination was studied for conditions characterized by fluctuating manifestations related to the menstrual cycle. Clinical trials and systematic reviews evaluated adult women, monitoring patient-reported outcomes for nervous tension and irritability. Evidence quality varies across studies, and data for sufficient consecutive cycles remain insufficient.

Evidence for Use in Muscle Cramps and Spasms

Research was evaluated in settings related to physical discomfort, specifically muscle cramps and spasms. The evidence includes RCTs, but many reviews focus heavily on magnesium alone. Research examined the combination in trials assessing short-term symptom patterns, often lasting up to four weeks. Comparative evidence is lacking for the specific combination product.

Understanding Long-Term Studies and Follow-up

The current evidence base is heavily skewed toward research exploring short-term symptom changes, usually with observation periods of four to eight weeks. Long-term outcomes and the durability of any response are not fully established. There is limited information for long-term outcomes for most conditions where this combination was studied for symptomatic relief.

Evidence in Special Populations

The combination was studied for conditions marked by functional limitations in specific groups, including women experiencing leg cramps. Data for certain groups remain insufficient, such as evidence for use in pediatric populations or older adults with complex conditions. Results apply only to the populations studied.

What Is Still Uncertain About Magnesium+B6 Pharmavit

Evidence highlights what is known and what is still uncertain. The certainty remains low for several areas because sample sizes were modest and evidence quality varies across studies. Long-term effects are not fully established, and comparative evidence is lacking to determine the specific role of the B6 component within the combination.

Key Studies & References

  1. Vitamin B6 (pyridoxine) Safety advisory - potential for dose-related adverse events.
  2. Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Magnesium+B6 Pharmavit (FAQ)

Q: Is Magnesium+B6 Pharmavit a prescription-only medicine?

A: The regulatory status of this combination is determined by the total daily dosage of the Vitamin B6 component and varies by national law. Products containing lower amounts of Vitamin B6 are generally available for general sale. However, those with higher B6 doses may require pharmacist oversight or a prescription, depending on the country's specific regulations for vitamin potency.


Q: I heard this drug is for stress, is that one of its official uses?

A: Official product documentation lists the medicine's primary purpose as correcting a confirmed deficiency of magnesium and/or Vitamin B6. While studies have explored the combination for reported symptoms associated with increased physiological strain, the official approved indications are focused on addressing an underlying deficiency state, not listing 'stress' as an approved indication in regulatory documents.


Q: Why do people take this medicine for symptoms like muscle cramps?

A: People commonly use this product because official health resources and studies link muscle cramps and twitching to known symptoms of a magnesium deficiency. The medicine is indicated for correcting this deficiency, which is consistent with its intended purpose.


Q: Are there any long-term effects of using this medicine regularly?

A: The most significant documented risk associated with prolonged use, especially at high doses of the Vitamin B6 component, is the potential for peripheral neuropathy (a form of nerve damage). This may cause symptoms like tingling or numbness in the hands and feet. Official documents describe that caution is warranted for prolonged use.


Q: I'm taking an antibiotic; is there a potential interaction with Magnesium+B6 Pharmavit?

A: Yes, regulatory documents note that the magnesium component can reduce the absorption of certain types of antibiotics, specifically Tetracyclines and Quinolone antibiotics. To mitigate this effect, official instructions describe separating the administration of these drugs by a specific time interval, which is often cited as two to six hours.


Q: Does the medicine interact with alcohol consumption?

A: Yes, chronic and excessive alcohol consumption is documented to increase the urinary excretion of magnesium. This may reduce the magnesium available in the body and could therefore work against the intended purpose of the medicine.


Q: What is the shelf life or expiry expectation for this product?

A: The medicine's shelf life is indicated by the expiry date printed on the packaging. The product must not be used after this date. This date typically refers to the last day of the month indicated on the label.


Q: Is it normal to feel a mild digestive upset when first starting Magnesium+B6 Pharmavit?

A: Gastrointestinal issues, such as diarrhea, nausea, and stomach upset, are listed among the common side effects of magnesium salts. These effects are generally related to the amount taken, and may be experienced when first starting use. According to regulatory documents, such effects may be temporary, and the severity is described as potentially being dose-related.


Q: If I miss a dose, what is the description of the recommended action in the patient leaflet?

A: Regulatory instructions describe that if a dose is forgotten, the missed dose is to be taken as soon as it is remembered. However, if the time for the next scheduled dose is near, the patient should simply take the next dose as usual. Official warnings state that patients must not take a double amount to compensate for a missed dose.


Q: What happens to the body if you stop taking the medicine suddenly?

A: Since the medicine is intended to correct a documented deficiency, stopping use abruptly before the deficiency is fully corrected may result in the gradual recurrence of the original symptoms that necessitated the treatment.


Q: Can I use this product if I have kidney issues, based on official safety information?

A: The medicine is contraindicated (should not be used) in patients with severe renal insufficiency (poor kidney function) due to a mandatory restriction to prevent magnesium accumulation. Patients with non-severe kidney issues is subject to conditional use, as dosage adjustment may be required in these populations.


Q: What is the risk of overdose described in regulatory documents for this drug?

A: An excessive intake can lead to hypermagnesemia (too much magnesium in the blood). Documented symptoms of overdose can include lethargy, facial flushing, diarrhea, low blood pressure, muscle weakness, and, in severe cases, serious cardiovascular or respiratory complications. The risk is heightened in individuals with kidney impairment.


Q: How is this medication typically eliminated from the body?

A: The magnesium component is primarily eliminated from the body by the kidneys through urinary excretion. The body uses this mechanism to regulate the amount of magnesium in the bloodstream, increasing excretion when a surplus is present.


Q: Is there official information available regarding the effects on mood or energy levels?

A: The components of the medicine are involved in key processes related to neurological function, including the production of neurotransmitters that regulate mood. Additionally, magnesium is essential for the activation of ATP, the molecule vital for cellular energy. Studies exploring these functional areas are consistent with the medicine's metabolic role.


Q: Is there a maximum time frame for which this medicine can be used as described in official sources?

A: Official documents state that the duration of use should be guided by clinical necessity, concluding once the magnesium deficit is corrected. Due to the potential for nerve damage (peripheral neuropathy) associated with the Vitamin B6 component, caution is warranted regarding prolonged use.


Q: Does Magnesium+B6 Pharmavit affect blood pressure readings?

A: Studies have examined the role of magnesium in regulating blood pressure. The magnesium component is recognized in pharmacological literature for mechanisms that can affect the regulation of vascular tone. Furthermore, official interaction warnings describe caution when combining this product with certain blood pressure medications.


Q: Can this drug cause sensitivity to sunlight according to the side effects list?

A: Sensitivity to sunlight (photosensitivity) is listed as a potential, though rare, side effect in connection with excessive intake of the Vitamin B6 component, especially when using high doses or for a prolonged duration.


Q: Is there a link between the use of this medicine and changes in sleep patterns?

A: Magnesium is known to support the nervous system, helping to regulate muscle and nerve activity. These functions are fundamentally related to the quality and maintenance of sleep. Deficiency symptoms of magnesium often include difficulty in falling or staying asleep.


Q: I read about a rare side effect; how often does this kind of side effect typically occur?

A: Official patient information categorizes side effects into frequency classes, such as common, uncommon, rare, and very rare. These classifications are based on the reported data collected from clinical trials and post-marketing surveillance, providing a factual measure of how often a side effect has been observed.


Q: Why do official sources sometimes mention caution when combining this with certain heart medications?

A: Caution is mentioned because the magnesium component can interfere with some heart medications. For example, it may reduce the absorption of Digoxin, or, when combined with medications like calcium channel blockers, it may affect the overall pharmacological action.


Q: What information is provided about potential interactions with Digoxin?

A: Official documents state that the magnesium component may decrease the plasma concentration (the amount absorbed into the blood) of the heart medication Digoxin. A time separation between administrations is described as being recommended to prevent this effect and ensure the heart medication works as intended.


Q: Is there a patient support phone number or resource listed on the official materials?

A: Patient information leaflets are required to list the manufacturer's contact details for reporting adverse events or seeking product information. Additionally, regulatory bodies often provide links to trusted, non-branded public resources on general health topics related to the medicine's components.


Q: Are there special considerations for people who follow a vegetarian or vegan diet?

A: The official documents, such as the Summary of Product Characteristics (SmPC), provide a complete list of all active and inactive ingredients (excipients) used in the formulation, including the tablet coating. These details can be reviewed to confirm the product's suitability for specific dietary preferences.


Q: Does this medicine have a known effect on laboratory test results?

A: Some components of supplements can potentially interfere with the results of certain laboratory tests, particularly those measuring mineral levels. Regulatory guidelines often recommend informing the testing provider or laboratory about the use of such medicines before having tests performed.


Q: Is this medicine typically recommended by official bodies for long-term health maintenance?

A: No. Official documentation defines the medicine's purpose as the correction of a confirmed deficiency state. Due to the known risk of side effects associated with prolonged use of the Vitamin B6 component, it is generally not recommended for indefinite long-term health maintenance.


Q: Why is Vitamin B6 included in this combination product?

A: Vitamin B6 (Pyridoxine) is included because it has been shown to assist in the cellular uptake and retention of the magnesium ion. This mechanism provides a metabolic synergy between the two active components, which may enhance the overall effectiveness of the product in correcting a deficiency.


Q: Are there dietary restrictions mentioned in the official instructions for use?

A: Official documents do not list general dietary restrictions, but they do advise that the medicine must be taken with meals to optimize absorption. Additionally, official warnings note that high doses of calcium salts and chronic alcohol consumption may negatively affect magnesium levels in the body.

Advertisements

How should Magnesium+B6 Pharmavit be stored and disposed of?

Storage Conditions

Official regulatory documents require that Magnesium+B6 Pharmavit be stored out of the sight and reach of children to prevent accidental ingestion. The product must be stored in the original packaging to ensure protection from light and moisture. Storage temperature is typically specified as room temperature, often defined as below 25 C or 30 C, and the tablets must not be frozen. Maintaining these conditions ensures the stability of the medicine until the labeled expiry date.

Disposal Instructions

Unused or expired tablets should be disposed of via a drug take-back program (e.g., pharmacy kiosk or law enforcement event) as the preferred method, or by following local regulations. Regulatory guidelines advise not to throw away this medicine via wastewater (e.g., flushing down the toilet). If a take-back option is unavailable, the tablets may be disposed of in the household trash mixed with an unappealing substance such as used coffee grounds or dirt, sealed in a bag, and then discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Magnesium+B6 Pharmavit found in:

A-Z Index: